Skip to main content
SpringerLink
Log in

Nasopharyngeal Cancer

  • Chapter
Head and Neck Cancer

Part of the book series: Cancer Treatment and Research ((CTAR,volume 114))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ho JHC. An epidemiologic and clinical study of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1978;4:183–205.

    Google Scholar 

  2. Lo KW, Cheung ST, Leung SF, et al. Hypermethylation of the p16 gene in nasopharyngeal carcinoma. Cancer Res 1996;56:2721–5.

    PubMed  CAS  Google Scholar 

  3. Chan AS, To KF, Lo KW, et al. High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Res 2000;60:5365–70.

    PubMed  CAS  Google Scholar 

  4. Lo KW, Teo PM, Hui AB, et al. High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res 2000;60:3348–53.

    PubMed  CAS  Google Scholar 

  5. Lo KW, Kwong J, Hui AB, et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 2001;61:3877–81.

    PubMed  CAS  Google Scholar 

  6. Huang DP, Lo KW, van Hasselt CA, et al. A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma. Cancer Res 1994;54:4003–6.

    PubMed  CAS  Google Scholar 

  7. Hui AB, Lo KW, Leung SF, et al. Detection of recurrent chromosomal and losses in primary nasopharyngeal carcinoma by comparative genomic hybridization. Int J Cancer 1999;82:498–503.

    Article  PubMed  CAS  Google Scholar 

  8. Shanmugaratnam K, Sobin LH. The World Health Organization histological classification of tumours of the upper respiratory tract and ear. A commentary on the second edition. Cancer 1993;71:2689–97.

    PubMed  CAS  Google Scholar 

  9. Krueger GR, Wustrow J. Current histological classification of nasopharyngeal carcinoma at Cologne University, in Grundman (ed): Cancer Campaign; Nasopharyngeal Carcinoma Vol 5, Stuttgart, Germany, Gustay Fisher verlag, pp. 11–15; 1981.

    Google Scholar 

  10. Reddy SP, Raslan WF, Gooneratne S, Kathuria S, Marks JE. Prognostic significance of keratinization in nasopharyngeal carcinoma. Am J Otolaryngol 1995;16(2):1038.

    Google Scholar 

  11. Marks JE, Phillips JL, Menck HR. The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer 1998;83(3):582–8.

    Article  PubMed  CAS  Google Scholar 

  12. Teo PML, Leung SF, Yu P, Tsao SY, Foo W, Shiu W. A comparison of Ho’s, International Union Against Cancer, and American Joint Committee Stage Classifications for Nasopharyngeal Carcinoma. Cancer 1991;67:434–439.

    PubMed  CAS  Google Scholar 

  13. Teo PML, Yu P, Lee WY, et al. Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radial Oncol Biol Phys 1996;36:291–304.

    CAS  Google Scholar 

  14. Lo Y.M.D., Chan L.Y.S., Lo K.W., et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 1999;59:1188–91.

    PubMed  CAS  Google Scholar 

  15. Chan A.T.C., Lo Y.M.D., Chan L.Y.S., et al. EBV DNA monitoring during chemotherapy for patients with undifferentiated nasopharyngeal carcinoma: A strong predictor of tumor response. (Abst.) Proc ASCO 2001;20:928.

    Google Scholar 

  16. Lo Y.M.D., Chan L.Y.S., Chan A.T.C., et al. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res 1999;59:5452–5.

    PubMed  CAS  Google Scholar 

  17. Lo Y.M.D., Chan A.T.C., Chan L.Y.S., et al. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. Cancer Res 2000;60:6878–81.

    PubMed  CAS  Google Scholar 

  18. O’Sullivan B, Chong V, Gospodarowicz MK et al. Nasopharyngeal carcinoma. Prognostic factors in Cancer 2nd edition. UICC TNM Project and Prognostic Factors Committee, 2001.

    Google Scholar 

  19. Lee AWM, Poon YF, Foo W, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: Overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 1992;23:261–270.

    PubMed  CAS  Google Scholar 

  20. Xia P, Fu KK, Wong GW, Akazawa C, Verhey LJ. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2000;48:329–337.

    Article  PubMed  CAS  Google Scholar 

  21. Chau RMC, Teo PML, Choi PHK, Cheung KY, Lee WY. Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma. Radioth Oncol 2001;58:143–153.

    CAS  Google Scholar 

  22. Teo PML, Leung SF, Lee WY, Zee B. Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: The existence of a dose-tumour-control relationship above conventional tumoricidal dose. Int J Radiat Oncol Biol Phys 2000;46:445–458.

    Article  PubMed  CAS  Google Scholar 

  23. Fu KK, Pajak TF, Trotti A, et al. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48:7–16.

    PubMed  CAS  Google Scholar 

  24. Teo P.M.L., Leung S.F., Chan A.T.C., et al. Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications. Int J Radiat Oncol Biol Phys 2000;48:1311–22.

    Article  PubMed  CAS  Google Scholar 

  25. Lee AWM, Sze WM, Yau TK, Yeung RM, Chappell R, Fowler JF. Retrospective analysis on treating nasopharyngeal carcinoma accelerated fractionation (6 fractions per week) in comparison conventional fractionation (5 fractions per week): report on control and normal tissue toxicity. Radiother Oncol 2001;58:121–130.

    Article  PubMed  CAS  Google Scholar 

  26. Chan ATC, Teo PML, Leung TWT, et al. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1995;33:569–577.

    Article  PubMed  CAS  Google Scholar 

  27. Rossi A, Molinari R, Boracchi P, et al. Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: Results of a 4-year multicenter randomized study. J Clin Oncol 1988;6:1401–1410.

    PubMed  CAS  Google Scholar 

  28. International Nasopharynx Cancer Study Group. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (≥ N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival. Int J Radiat Oncol Biol Phys 1996;35:463–469.

    Google Scholar 

  29. Chua DTT, Sham JST, Choy D, et al. Preliminary report of the Asian-Oceanian clinical oncology association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Cancer 1998;83:2270–2283.

    Article  PubMed  CAS  Google Scholar 

  30. Al-Sarraf M, LeBlanc M, Giri PGS, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099. J Clin Oncol 1998;16:1310–1317.

    PubMed  CAS  Google Scholar 

  31. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. Lancet 2000:355.

    Google Scholar 

  32. Chan AT, Teo PM, Ngan RK, et al. A phase III randomized trial comparing concurrent chemotherapy-radiotherapy with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. (Abst.) Proc ASCO 2000;19:1637.

    Google Scholar 

  33. Lee AWM, Law SCK, Foo W, et al. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976–1985: Survival after local recurrence. Int Radiat Oncol Biol Phys 1993;26:773–782.

    CAS  Google Scholar 

  34. Wang CC. Re-irradiation of recurrent nasopharyngeal carcinoma: Treatment techniques and results. Int J Radiat Oncol Biol Phys 1987;13:953–956.

    PubMed  CAS  Google Scholar 

  35. Teo PML, Kwan WH, Chan ATC, et al. How successful is high-dose (≥ 60Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys 1998;40:897–913.

    Article  PubMed  CAS  Google Scholar 

  36. Choy D, Sham JST, Wei WI, Ho CM, Wu PM. Transpalatal insertion of radioactive gold grain for the treatment of persistent and recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1993;25:505–512.

    PubMed  CAS  Google Scholar 

  37. King WWK, Ku PKM, Mok CO, Teo PML. Nasopharyngectomy in the treatment of recurrent nasopharyngeal carcinoma: a twelve-year experience. Head and Neck 2000;22:215–222.

    PubMed  CAS  Google Scholar 

  38. Wei WI, Lam KH, Sham JST. New approach to nasopharynx: The maxillary swing approach. Head and Neck 1991;13:200–207.

    PubMed  CAS  Google Scholar 

  39. To EWH, Teo PML, Ku PKM, Pang PCW. Nasopharyngectomy for recurrent nasopharyngeal carcinoma: an innovative transnasal approach through a mid-face deglove incision with stereotactic navigation guidance. Brit J Oral Maxillofacial Surgery 2001;39:55–62.

    CAS  Google Scholar 

  40. Chan A.T.C., Teo P.M.L., Leung W.T., Johnson P.J. Role of chemotherapy in the management of nasopharyngeal carcinoma. Cancer 1998;82:1003–12.

    Article  PubMed  CAS  Google Scholar 

  41. Zheng X, Hu L, Chen F, Christensson B. Expression of Ki67 antigen, epidermal growth factor receptor and Epstein-Barr virus-encoded latent membrane protein (LMP1) in nasopharyngeal carcinoma. Eur J Cancer Oral Oncol 1994;30B5:290–295.

    Google Scholar 

  42. Poon TCW, Chan ATC, To KF, et al. Expression and prognostic significance of epidermal growth factor receptor and HER2 protein in nasopharyngeal carcinoma. Proc ASCO 2001;20:913.

    Google Scholar 

  43. Lee SP, Chan ATC, Cheung ST, et al. Cytotoxic T lymphocyte control of Epstein-Barr virus in nasopharyngeal carcinoma (NPC): EBV-specific CTL response in the blood and tumour of NPC patients and the antigen processing function of the tumour cells. J Immunology 00;165:573–82.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chinese University of Hong Kong, HKSAR, China

    Anthony TC Chan M.D., M. D. Chan, Peter ML Teo M.D., M. D. Teo, Philip J Johnson M.D. & M. D. Johnson

Authors
  1. Anthony TC Chan M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. D. Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter ML Teo M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. D. Teo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Philip J Johnson M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. D. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Evanston Northwestern Healthcare, Evanston, IL

    Brockstein Bruce M.D.  & Masters Gregory M.D.  & 

  2. Robert H. Lurie Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago, IL

    Brockstein Bruce M.D.  & Masters Gregory M.D.  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Kluwer Academic Publishers

About this chapter

Cite this chapter

Chan, A.T., Chan, M.D., Teo, P.M., Teo, M.D., Johnson, P.J., Johnson, M.D. (2004). Nasopharyngeal Cancer. In: Bruce, B., Gregory, M. (eds) Head and Neck Cancer. Cancer Treatment and Research, vol 114. Springer, Boston, MA. https://doi.org/10.1007/0-306-48060-3_11

Download citation

  • DOI: https://doi.org/10.1007/0-306-48060-3_11

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4020-7336-6

  • Online ISBN: 978-0-306-48060-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation